



      UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                   WASHINGTON, D.C. 20549
                              
                          FORM 8-K
                              
                       CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange
Act of 1934

                        JUNE 30, 1998
                        -------------  
              (Date of earliest event reported)


         LABORATORY CORPORATION OF AMERICA HOLDINGS
         ------------------------------------------
   (Exact name of registrant as specified in its charter)
                              
                              
      DELAWARE              1-11353             13-3757370
      --------              -------             ----------
  (State or other         (Commission         (IRS Employer
  jurisdiction of         File Number)        Identification
  incorporation)                              Number)
                              
                              
   358 SOUTH MAIN STREET, BURLINGTON, NORTH CAROLINA 27215
   -------------------------------------------------------
          (Address of principal executive offices)
                              
                        336-229-1127
                        ------------
    (Registrant's telephone number, including area code)
                              
<PAGE>
<PAGE>

ITEM 5. OTHER EVENTS

On June 30, 1998, the Company issued a press release
announcing that the Antivirogram-TM- and the VircoGEN-TM-, two new
diagnostic testing procedures enabling physicians to
evaluate resistance of HIV to antiretroviral drugs, will be
available for commercial use on July 20, 1998 exclusively
from LabCorp facilities in the U.S.  These new testing
systems are an important advance in optimizing treatment
choices in the fight against HIV/AIDS.

ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL
        INFORMATION AND EXHIBITS

 (c)  Exhibit
      20  Press release of the Company dated June 30, 1998.

<PAGE>
<PAGE>

                         SIGNATURES

Pursuant to the requirements of the Securities and
Exchange Act of 1934, the registrant has duly caused this
report to be signed on its behalf by the undersigned
hereunto duly authorized.

               LABORATORY CORPORATION OF AMERICA HOLDINGS
               ------------------------------------------
                              (Registrant)

                    By:/s/ BRADFORD T. SMITH
                       ------------------------------                      
                           Bradford T. Smith
                           Executive Vice President,
                           General Counsel, Secretary
                           and Compliance Officer



Date: July 7, 1998
<PAGE>
<PAGE>


